[Clinical and instrumental evaluation of the effect of tiapride in senile involutional syndrome].
Twenty elderly patients with pathological cerebral involution were treated with tiapride (200 mg/die) and investigated with psycho-clinical tests. After three months, the group of patients demonstrated a significant improvement compared to a control group treated with placebo.
Bettini
R
R
Divisione di Medicina, Ospedale Filippo del Ponte, Varese.
Ferrari
M
M
Gobbi
G
G
Volanti
F
F
Piccinelli
O
O
D000368:Aged; D001077:Aptitude Tests; D003704:Dementia / Q000188:drug therapy* / Q000523:psychology; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D010919:Placebos; D013976:Tiapamil Hydrochloride / Q000494:pharmacology / Q000627:therapeutic use*
D010919:Placebos; D013976:Tiapamil Hydrochloride
Valutazione clinica e strumentale dell'effetto della tiapride sulla sindrome involutiva senile.